Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Pleural Effusion, Malignant 1

Interventions

sintilimab 1diphtheria-tetanus-five component acellular pertussis-inactivated poliomyelitis -Haemophilus influenzae type b conjugate vaccine 1Vincristine 1Sevoflurane 1Rituximab 1Propofol 1Pleurodesis 1Mitoxantrone 1Methotrexate 1Introns 1Interferon alpha-2 1Idarubicin 1Gastrointestinal Microbiome 1Drug Therapy 1Docetaxel 1Dexamethasone 1Dasatinib 1Danazol 1Cytarabine 1Clorazepate Dipotassium 1Carboplatin 1Anesthesia, Epidural 123-valent pneumococcal capsular polysaccharide vaccine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × NETWORK × Pleurodesis × Clear all
NCT01670786 2014-05-13

Safety Profile of Iodopovidone as an Agent for Pleurodesis in Malignant Pleural Effusion

Grupo de Pesquisa em Pleura e Oncologia Toracica

Phase 4 Completed
60 enrolled
Thoracic

Pleural Effusion, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡